Biotech Values

[biomaven0]

>>LLY/INCY RA

Looks like excellent results to me. The slope of the curves suggests that there would be continued improvement after 12 weeks, perhaps indicating that this will be a somewhat better drug than Pfizer's from an efficacy perspective.

Not hitting JAK3 has always been touted by INCY as a safety advantage, but there just isn't enough data here to see whether that claim is valid or not.

Peter